Compare Stocks: CALC, NTRB, CLNN, and RYM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CALC CalciMedica	$2.17 -1.4%	$3.59	$2.00 ▼ $36.00	$14.82M	0.83	89,031 shs	94,119 shs
CLNN Clene	$3.85 -3.5%	$5.15	$3.72 ▼ $13.50	$49.47M	0.95	96,670 shs	122,559 shs
NTRB Nutriband	$5.97 +6.0%	$3.47	$2.80 ▼ $8.63	$72.57M	2.03	37,696 shs	93,622 shs
RYM RYTHM	$25.71 +2.7%	$22.28	$14.00 ▼ $53.65	$57.20M	9.44	11,245 shs	5,259 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CALC CalciMedica	0.00%	-6.55%	-39.04%	-59.06%	-86.52%
CLNN Clene	0.00%	-8.98%	-27.90%	-29.36%	-31.13%
NTRB Nutriband	0.00%	+33.86%	+104.45%	+66.76%	-5.98%
RYM RYTHM	0.00%	+11.07%	+16.45%	+1.63%	+2,571,299,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CALC CalciMedica	$2.17 -1.4%	$3.59	$2.00 ▼ $36.00	$14.82M	0.83	89,031 shs	94,119 shs
CLNN Clene	$3.85 -3.5%	$5.15	$3.72 ▼ $13.50	$49.47M	0.95	96,670 shs	122,559 shs
NTRB Nutriband	$5.97 +6.0%	$3.47	$2.80 ▼ $8.63	$72.57M	2.03	37,696 shs	93,622 shs
RYM RYTHM	$25.71 +2.7%	$22.28	$14.00 ▼ $53.65	$57.20M	9.44	11,245 shs	5,259 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CALC CalciMedica	0.00%	-6.55%	-39.04%	-59.06%	-86.52%
CLNN Clene	0.00%	-8.98%	-27.90%	-29.36%	-31.13%
NTRB Nutriband	0.00%	+33.86%	+104.45%	+66.76%	-5.98%
RYM RYTHM	0.00%	+11.07%	+16.45%	+1.63%	+2,571,299,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CALC CalciMedica	2.20	Hold	$50.00	2,204.15% Upside
CLNN Clene	2.71	Moderate Buy	$33.25	763.64% Upside
NTRB Nutriband	1.50	Reduce	N/A	N/A
RYM RYTHM	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest CALC, NTRB, CLNN, and RYM Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/27/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/27/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/20/2026	CALC CalciMedica	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
8/17/2026	CLNN Clene	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/13/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/13/2026	RYM RYTHM	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/13/2026	CALC CalciMedica	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/30/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/29/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/29/2026	CALC CalciMedica	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral

(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CALC CalciMedica	N/A	N/A	N/A	N/A	$0.81 per share	N/A
CLNN Clene	$200K	247.36	N/A	N/A	($1.93) per share	-1.99
NTRB Nutriband	$2.04M	35.59	N/A	N/A	$0.55 per share	10.85
RYM RYTHM	$17.28M	3.24	N/A	N/A	$17.94 per share	1.43

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CALC CalciMedica	-$29.56M	-$6.80	N/A	N/A	N/A	N/A	-863.40%	-155.24%	11/11/2026 (Estimated)
CLNN Clene	-$26.17M	-$3.50	N/A	N/A	N/A	-20,063.96%	N/A	-137.04%	11/12/2026 (Estimated)
NTRB Nutriband	-$8.23M	-$0.53	N/A	N/A	N/A	-448.25%	-112.64%	-97.86%	9/30/2026 (Estimated)
RYM RYTHM	-$33.26M	-$10.53	N/A	N/A	N/A	-6.20%	-12.57%	-2.60%	N/A

Latest CALC, NTRB, CLNN, and RYM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/4/2026	Q2 2027	NTRB Nutriband	N/A	-$0.07	N/A	-$0.07	N/A	$0.44 million
8/14/2026	Q2 2026	CLNN Clene	-$0.3680	-$1.08	-$0.7120	-$1.08	$0.06 million	$0.09 million
8/11/2026	Q2 2026	CALC CalciMedica	-$1.4250	-$0.45	+$0.9750	-$2.25	N/A	N/A
8/4/2026	Q2 2026	RYM RYTHM	N/A	$0.09	N/A	$0.09	N/A	$23.02 million
6/11/2026	Q1 2027	NTRB Nutriband	N/A	-$0.10	N/A	-$0.10	N/A	$0.43 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CALC CalciMedica	N/A	N/A	N/A	N/A	N/A
CLNN Clene	N/A	N/A	N/A	N/A	N/A
NTRB Nutriband	N/A	N/A	N/A	N/A	N/A
RYM RYTHM	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CALC CalciMedica	1.67	5.58	5.58
CLNN Clene	N/A	3.07	3.07
NTRB Nutriband	N/A	5.26	5.11
RYM RYTHM	N/A	0.59	0.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CALC CalciMedica	N/A
CLNN Clene	23.28%
NTRB Nutriband	19.70%
RYM RYTHM	5.98%

Insider Ownership

Company	Insider Ownership
CALC CalciMedica	28.25%
CLNN Clene	28.30%
NTRB Nutriband	52.21%
RYM RYTHM	3.48%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CALC CalciMedica	30	6.83 million	4.90 million	No Data
CLNN Clene	100	12.85 million	9.21 million	No Data
NTRB Nutriband	10	12.16 million	5.81 million	Not Optionable
RYM RYTHM	140	2.18 million	2.10 million	N/A

CALC, NTRB, CLNN, and RYM Headlines

Recent News About These Companies

Analyzing RYTHM (RYM) and Its Competitors

September 5 at 3:45 AM | americanbankingnews.com

RYTHM (NASDAQ:RYM) Trading 2% Higher - What's Next?

August 26, 2026 | americanbankingnews.com

RYTHM (NASDAQ:RYM) Shares Up 2% - What's Next?

August 26, 2026 | marketbeat.com

RYTHM Introduces Lifted Lemon, a New THC Twist on Iced Tea and Lemonade

August 20, 2026 | globenewswire.com

RYTHM Inc

August 19, 2026 | markets.ft.com

RYTHM Shareholders Approve Dilutive Equity Issuance Changes

August 11, 2026 | tipranks.com

RYTHM Swings to Earnings in Q2 on THC Beverage Growth

August 7, 2026 | zacks.com

RYTHM, Inc. Reports Record Second-Quarter 2026 Revenue Growth and Strong THC Beverage Momentum

August 4, 2026 | quiverquant.comQ

RYTHM, Inc. Reports Second Quarter 2026 Results

August 4, 2026 | globenewswire.com

RYTHM (NASDAQ:RYM) Trading Up 14% – Time to Buy?

August 4, 2026 | defenseworld.netD

RYTHM, Inc. (RYM) Stock Major Holders - Yahoo Finance

July 27, 2026 | ca.finance.yahoo.com

Señorita Brings THC Beverages to Lollapalooza for the First Time

July 23, 2026 | globenewswire.com

Rythm Stock Short Interest Report | NASDAQ:RYM | Benzinga

July 17, 2026 | benzinga.com

RYTHM (NASDAQ:RYM) Director Sells 2,250 Shares

June 19, 2026 | insidertrades.com

RYTHM Inc.

May 16, 2026 | marketwatch.com

Señorita Named Official THC Beverage Partner of Opry Entertainment Group Venues

May 14, 2026 | globenewswire.com

Rythm Inc Ordinary Shares RYM

May 13, 2026 | morningstar.comM

RYTHM Stock Price History

May 12, 2026 | investing.com

RYTHM's Q1 Earnings Rise Y/Y on Licensing Agreement Benefits

May 11, 2026 | zacks.com

Navy Pier Names RYTHM as Its Official THC Beverage Partner

May 8, 2026 | globenewswire.com

RYTHM, Inc. Reports First Quarter 2026 Results

May 5, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CALC, NTRB, CLNN, and RYM Company Descriptions

CalciMedica NASDAQ:CALC

$2.17 -0.03 (-1.36%)

As of 09/4/2026 04:00 PM Eastern

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops CM6336, an oral CRAC channel inhibitors for chronic inflammatory indications; and Auxora, for the treatment of acute ulcerative colitis and allergic asthma. The company is based in La Jolla, California.

Clene NASDAQ:CLNN

$3.85 -0.14 (-3.51%)

As of 09/4/2026 04:00 PM Eastern

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Nutriband NASDAQ:NTRB

$5.97 +0.34 (+6.04%)

As of 09/4/2026 04:00 PM Eastern

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

RYTHM NASDAQ:RYM

$25.71 +0.67 (+2.69%)

As of 09/4/2026 03:56 PM Eastern

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CALC, NTRB, CLNN, and RYM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CALC, NTRB, CLNN, and RYM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CALC, NTRB, CLNN, and RYM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CALC, NTRB, CLNN, and RYM Company Descriptions

CalciMedica NASDAQ:CALC

Clene NASDAQ:CLNN

Nutriband NASDAQ:NTRB

RYTHM NASDAQ:RYM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CALC, NTRB, CLNN, and RYM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CALC, NTRB, CLNN, and RYM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CALC, NTRB, CLNN, and RYM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CALC, NTRB, CLNN, and RYM Company Descriptions

CalciMedica NASDAQ:CALC

Clene NASDAQ:CLNN

Nutriband NASDAQ:NTRB

RYTHM NASDAQ:RYM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools